Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Apr 6;19(2):367–374. doi: 10.1016/j.cgh.2020.03.067

Table 3:

Impact of time difference between liver biopsy and VCTE on performance of VCTE.

Predictor Outcome AUROC P-value from test of independence of AUROC
VCTE and biopsy within 30 days (N=38) VCTE and biopsy more than 30 days (N=61)
STEATOSIS GRADE
CAP 0 vs. 1–3 0.89 (0.78, 1.0) 0.85 (0.74, 0.95) 0.5697
0–1 vs. 2–3 0.92 (0.82, 1.0) 0.96 (0.91, 1.0) 0.4667
0–2 vs. 3 0.77 (0.63, 0.91) 0.95 (0.90, 1.0) 0.0174
FIBROSIS STAGE
LSM 0 vs. 1–4 0.77 (0.61, 0.92) 0.86 (0.76, 0.95) 0.3447
0–1 vs. 2–4 0.82 (0.59, 1.0) 0.92 (0.84, 1.0) 0.3882
0–2 vs. 3–4 0.96 (0.90, 1.0) 0.97 (0.92, 1.0) 0.8326
0–3 vs. 4 0.99 (0.97, 1.0) 0.96 (0.91, 1.0) 0.2270